Arthritis Specialists in Attica, Indiana - Arthritis Specialists in Attica, IN - Yellow Pages Directory Inc.
Green Yellow Pages
Find a Business Near: Attica, IN                    
Enter Business Name or Keyword       Search by Phone
Requires City and State or Zip Code       Zip code finder

Business Owner?

List Your Business »

Home ::: Indiana ::: Attica ::: Arthritis Specialists

Arthritis Specialists in Attica, IN

Standard Listings

Business Listing   Brenner Hugo MD - Attica, IN - Phone: (765) 762-6092


Business Listing   Broadie Thomas A MD - Attica, IN - Phone: (765) 762-3006


Business Listing   Petrich Peter R MD - Attica, IN - Phone: (765) 762-2421


Business Listing   Petrich- Peter R MD - Attica, IN - Phone: (765) 762-3273


Business Listing   Ringer William A MD - Attica, IN - Phone: (765) 762-3497


Don't see your business here? Add it and appear here!

Helpful Definition for: Arthritis Specialists


'Arthritis Specialists' are medical professionals who are responsible for providing treatment to patients affected with arthritis. There are many forms of arthritis, the common being osteoarthritis and rheumatoid arthritis in Attica. For treating them, clinical tests like blood tests, radiology,etc, are done and after the detection, arthritis specialists give the necessary treatment for their recovery. In Attica, the treatment differs according to the type of arthritis detected and arthritis specialists treat them accordingly.

At the beginning of medication, the arthritis specialists in Attica give medicines having less power and increase as and when required. In Attica, both physical as well as occupational therapy is given by the arthritis specialist for relieving the patients from the excruciating pain of arthritis.

Recent Business News for: Arthritis Specialists

Chelsea Therapeutics skids as study fails - BusinessWeek

Chelsea Therapeutics skids as study failsBusinessWeekShare of Chelsea Therapeutics International Ltd. plunged Thursday after the company said it is ending studies of a potential treatment for rheumatoid arthritis. The company announced the decision while reporting results from a midstage clinical trial ...and more »